Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett Wagner Mackenzie

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
International Forum of Allergy & Rhinology|February 27, 2023
Bacterial communities in the nasal passage of postviral olfactory dysfunction patientsKristi Biswas, Vijay R Ramakrishnan, Elisabeth Hollemann, et al.
Scientific Reports|November 10, 2021
Characterising clinical Staphylococcus aureus isolates from the sinuses of patients with chronic rhinosinusitisBrett Wagner Mackenzie, Melissa Zoing, Fiona Clow, et al.
The Laryngoscope|January 16, 2023
In vitro Nasodine Can be an Effective Antibiofilm Agent for Biofilms that May Cause CRSSamuel J M Hale, Christian A Lux, Raymond Kim, et al.
Frontiers in Immunology|October 5, 2018
Inflammatory Endotypes and Microbial Associations in Chronic RhinosinusitisMichael Hoggard, Sharon Waldvogel-Thurlow, Melissa Zoing, et al.
Msphere|February 8, 2019
Comparison of Subtyping Approaches and the Underlying Drivers of Microbial Signatures for Chronic RhinosinusitisKristi Biswas, Raewyn Cavubati, Shan Gunaratna, et al.
International Forum of Allergy & Rhinology|July 16, 2024
A methodological pipeline for the preclinical evaluation of novel topical agents for the treatment of CRSSamuel J M Hale, Christian A Lux, James E Willoughby, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 26, 2020
Oral antibiotics used in the treatment of chronic rhinosinusitis have limited penetration into the sinonasal mucosa: a randomized trialJoey Siu, Lilian Klingler, Yi Wang, et al.
International Forum of Allergy & Rhinology|April 20, 2021
Sinonasal and gastrointestinal bacterial composition and abundance are stable after 1 week of once-daily oral antibiotic treatment for chronic rhinosinusitisJoey Siu, Brett Wagner Mackenzie, Lilian Klingler, et al.
Microbiology Spectrum|January 3, 2024
Polymyxin B and ethylenediaminetetraacetic acid act synergistically against <i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i>Samuel J M Hale, Alan J Cameron, Christian A Lux, et al.
Plos One|October 5, 2016
Integrity of the Human Faecal Microbiota following Long-Term Sample StorageElahe Kia, Brett Wagner Mackenzie, Danielle Middleton, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
International Forum of Allergy & Rhinology|February 27, 2023
Bacterial communities in the nasal passage of postviral olfactory dysfunction patientsKristi Biswas, Vijay R Ramakrishnan, Elisabeth Hollemann, et al.
Scientific Reports|November 10, 2021
Characterising clinical Staphylococcus aureus isolates from the sinuses of patients with chronic rhinosinusitisBrett Wagner Mackenzie, Melissa Zoing, Fiona Clow, et al.
The Laryngoscope|January 16, 2023
In vitro Nasodine Can be an Effective Antibiofilm Agent for Biofilms that May Cause CRSSamuel J M Hale, Christian A Lux, Raymond Kim, et al.
Frontiers in Immunology|October 5, 2018
Inflammatory Endotypes and Microbial Associations in Chronic RhinosinusitisMichael Hoggard, Sharon Waldvogel-Thurlow, Melissa Zoing, et al.
Msphere|February 8, 2019
Comparison of Subtyping Approaches and the Underlying Drivers of Microbial Signatures for Chronic RhinosinusitisKristi Biswas, Raewyn Cavubati, Shan Gunaratna, et al.
International Forum of Allergy & Rhinology|July 16, 2024
A methodological pipeline for the preclinical evaluation of novel topical agents for the treatment of CRSSamuel J M Hale, Christian A Lux, James E Willoughby, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 26, 2020
Oral antibiotics used in the treatment of chronic rhinosinusitis have limited penetration into the sinonasal mucosa: a randomized trialJoey Siu, Lilian Klingler, Yi Wang, et al.
International Forum of Allergy & Rhinology|April 20, 2021
Sinonasal and gastrointestinal bacterial composition and abundance are stable after 1 week of once-daily oral antibiotic treatment for chronic rhinosinusitisJoey Siu, Brett Wagner Mackenzie, Lilian Klingler, et al.
Microbiology Spectrum|January 3, 2024
Polymyxin B and ethylenediaminetetraacetic acid act synergistically against <i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i>Samuel J M Hale, Alan J Cameron, Christian A Lux, et al.
Plos One|October 5, 2016
Integrity of the Human Faecal Microbiota following Long-Term Sample StorageElahe Kia, Brett Wagner Mackenzie, Danielle Middleton, et al.
Pageof 4